Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The acquisition is expected to be completed in the coming days.
December 16, 2024
By: Charlie Sternberg
After receiving a green light from both U.S. and EU antitrust regulators, all regulatory closing conditions relating to the review of Novo Holdings A/S’s pending acquisition of Catalent Inc. have been fulfilled. The parties are now free to close the transaction, as well as Novo Nordisk’s subsequent acquisition of three Catalent manufacturing sites from Novo Holdings A/S. The acquisition of Catalent is part of Novo Nordisk’s broader strategy to expand its manufacturing capabilities and secure supply chain resilience. By integrating Catalent’s extensive network of facilities and expertise, Novo Nordisk aims to enhance its ability to deliver innovative therapies to patients worldwide. As previously announced, Novo Nordisk also plans to acquire three Catalent manufacturing sites from Novo Holdings A/S. This additional acquisition is expected to further strengthen Novo Nordisk’s manufacturing footprint and operational efficiency. While the acquisition is expected to positively impact Novo Nordisk’s long-term growth, it will have a short-term impact on the company’s financial performance. The company anticipates a low single-digit negative impact on operating profit growth in 2024 and a mid single-digit negative impact in 2025. Additionally, the acquisition will increase the company’s debt levels and negatively impact net financial items.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !